Stock Guru Featured Company: AtheroNova Inc. (AHRO.OB)
AtheroNova, Inc. is a development stage biotech company focused on discovering, researching, developing and licensing novel compounds designed to reduce or eliminate atherosclerotic plaque deposits. By reducing or eliminating atherosclerotic plaque deposits, the company would address the most lucrative segments of the multi-billion dollar prescription drug market: cardiology and stroke prevention. Existing classes of atherosclerotic drugs, including statins, have demonstrated tremendous market success, rapidly achieving blockbuster status and billions of dollars in sales. However, statins, including the biggest blockbuster of all time, Lipitor, do not effectively reduce plaque. The enormous market success of statins is due to the fact that…